Marrone Bio Innovations (MBII) 10-Q2020 Q1 Quarterly report

Filed: 11 May 20, 5:18pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	Coll freshman Avg

New words: Addendum, administered, Anasac, antidilution, appeal, appraised, bacterium, bear, bid, biological, Browning, care, cased, chain, Chile, clause, comparison, complementary, confidence, consecutive, consent, conserve, conserving, constant, corn, corroborated, costly, counterpart, cure, daily, deem, deficiency, delist, delisted, delisting, denote, Department, disposition, distancing, Dr, driven, dropping, earliest, economy, emerge, emergency, epidemic, essential, eventual, exit, experienced, fail, fewer, forgiven, frequently, fully, Fundamental, Geometric, globe, governmental, grace, hard, heavily, Helsinki, hierarchy, identical, indefinite, input, insect, institutional, intention, invoked, law, lay, lesser, mandated, mandatory, median, mid, mildew, mite, mold, mortgage, Motion, nakamurai, Nasdaq, nematicide, nematode, notice, notification, notify, observable, occurrence, orderly, outbreak, outlook, Oxide, Pacesetter, pandemic, panel, Paycheck, peer, peroxyacetic, PPP, preemption, prepay, prepayment, prevent, prevented, Program, prolonged, prudent, publicly, quoted, ration, reclassified, recommendation, redeem, refinance, regain, reliance, Relief, remotely, repay, resale, restore, retire, reverse, safety, SBA, shelf, shelter, simulation, Small, social, soybean, split, spread, spring, stabilize, statewide, stockholder, strain, strive, subtsugaeandBurkholderia, successful, sum, suppling, suspended, tolled, tranche, turf, type, UBP, undiscounted, unfavorable, unobservable, unprecedented, unsuccessful, upfront, vi, violation, waived, wheat, white, workforce, worldwide, written, Zelto

Removed: absorbed, accredited, actively, addressing, affiliate, aforementioned, agent, amortized, Anderson, annualized, application, ASU, bacteria, began, bill, biofumigant, bioherbicide, biopesticide, bona, borrowing, breached, cancellation, claim, clarity, classified, collateralized, collective, commenced, commencement, comparability, comparable, complaint, complex, Concurrent, consummation, contemplated, conversion, convert, converted, Court, cumulative, dated, debtor, deducting, defendant, depending, dispute, disputed, documented, dollar, Dwight, earned, effectively, enacted, Ennoble, entirety, entitled, exclusivity, executed, expired, extending, extinguished, facilitated, FASB, feature, feet, final, fluctuate, forward, funded, fungi, government, guidance, holder, implicit, index, induced, informed, infringing, insolvent, Ivy, Jaffray, landlord, leasing, licensed, licensing, lien, mentioned, mitigating, modified, month, naturally, noncurrent, November, occurring, offered, office, opening, original, owner, package, partial, party, pending, permitted, personal, Piper, placement, point, policy, powder, practical, priority, produce, putting, ranging, rebate, receipt, recording, Reed, refinancing, renegotiated, renew, renewal, renewed, repayable, repurchase, repurchased, requiring, residual, restated, restructuring, retain, retained, retrospective, reverted, revised, rollout, royalty, save, Science, section, separate, serve, servicing, similarly, situation, Snyder, space, specifically, square, SSP, standalone, standard, statutory, sublease, sublessee, subordinated, Superior, Supplementary, taxable, taxation, technology, thereto, thereunder, tied, titled, Topic, transition, transparency, trend, troubled, unapproved, unchanged, underwriting, unregistered, vacant, VIP, volume, Waddell, Zequanox

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated MBII transcripts

MBII similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Pamela G. Marrone, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Marrone Bio Innovations, Inc. on Form 10-Q for the fiscal quarter ended March 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Marrone Bio Innovations, Inc.

Date: May 11, 2020

	By:	/s/ Pamela G. Marrone
	Name:	Pamela G. Marrone
	Title:	Chief Executive Officer

I, James B. Boyd, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Marrone Bio Innovations, Inc. on Form 10-Q for the fiscal quarter ended March 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Marrone Bio Innovations, Inc.

Date: May 11, 2020

	By:	/s/ James B. Boyd
	Name:	James B. Boyd
	Title:	President and Chief Financial Officer

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.